Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac
The main objective of the study is to estimate the proportion of children, born between the 01/01/2002 and the 06/23/200, living around Dieppe (cantons Dieppe est, Dieppe Ouest and Offranville), vaccinated by MenBVac, with a serum bactericidal activity against B:14,P1-7,16 clone related to a protection (>= 4), before and after the third MenBvac vaccination.
|Study Design:||Time Perspective: Prospective|
|Official Title:||EVALUATION DE LA REPONSE IMMUNITAIRE CONTRE LA SOUCHE DE NEISSERIA MENINGITIDIS B:14,P1.7,16|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00450554
|Rouen, Seine Maritime, France, 76000|
|Principal Investigator:||CARON François, Professor||Service des Maladies Intectieuses et Tropicales|